UPC_CFI_14/2023

The Munich Local Division issued an order pursuant to Art. 33(3)(b) UPCA, granting all parties' unanimous request to refer the counterclaim for revocation to the Central Division, while deciding to proceed with the infringement proceedings at the Local Division and reserving the possibility to stay the infringement action pending the revocation outcome.

The Munich Local Division issued a procedural order in the Amgen v. Sanofi/Regeneron infringement proceedings, setting provisional dates for the interim conference and oral hearing and granting the defendants a short time extension for filing their statement of defence until 8 January 2024.

Duplicate version of the 2 January 2024 Munich Local Division procedural order in Amgen v. Sanofi/Regeneron, setting provisional hearing dates and granting defendants a brief time extension for the statement of defence.

Third version of the 2 January 2024 Munich Local Division procedural order in Amgen v. Sanofi/Regeneron, setting provisional hearing dates and granting defendants a brief time extension for the statement of defence.

The Munich Local Division issued an order regarding a change of language of proceedings from German to English in the infringement action by Amgen against Sanofi and Regeneron entities concerning EP 3 666 797.

The Munich Local Division addressed pleading deadlines in Amgen v. Sanofi/Regeneron, ruling that a claim can be validly filed and served without exhibits (with later filing announced), and that the hearing right for late exhibits can be safeguarded by adjusting the timetable.

The Munich Local Division issued a further case management order establishing that different procedural requests must be lodged in separate workflows for clarity, and addressed the parties' multiple procedural motions concerning deadlines, service dates, and consolidation with the revocation action.

The Munich Local Division issued a procedural order requiring different applications to be submitted through separate CMS workflows, and addressed the question of whether the counterclaim for revocation should be joined with the infringement action.

The Munich Local Division issued a case management order addressing the parties' requests regarding service dates, deadline alignment for Regeneron, and the proposed consolidation of the infringement action with a revocation action filed before the Central Division, scheduling further procedural steps.

The Munich Local Division withdrew the preliminary separation order for Regeneron Pharmaceuticals after Amgen withdrew its separation request following successful service on Regeneron via email, and declared the earlier provisional order moot.

The Munich Local Division issued a preliminary order in Amgen's SEP infringement action against Sanofi, addressing service of claim on Regeneron Pharmaceuticals and proposing separation of that defendant's proceedings to avoid delay, pending hearing of the served parties.